Our advisory board of industry leaders support and advise ViVitro’s team on global growth and broadened cardiovascular device testing applications.
John G. Webb, M.D., FRCPC is a Canadian interventional cardiologist and the McLeod Professor of Heart Valve Intervention at the University of British Columbia. He is most well known for performing the first retrograde transfemoral and the first transapical transcatheter aortic valve implantation in the world both in 2005. In addition, he was an investigator in the PARTNER trial, a randomized clinical trial demonstrating the efficacy of TAVI compared to aortic valve replacement and medical intervention.
For over 30 years, Dr. Thubrikar has been a leading authority on the aortic valve. From 2007 to 2010, Dr. Thubrikar served as Director of the Biomedical Engineering Program and Professor of Mechanical Engineering at the South Dakota School of Mines and Technology. Previously, Dr. Thubrikar served as Edwards Distinguished Research Scientist at Edwards Lifesciences Corp.; as Director of Biomedical Engineering at the Heineman Medical Research Center at Carolina’s Medical Center with a joint appointment at the University of North Carolina; and as Director of Surgical Research in the Department of Surgery at the University of Virginia Health Sciences Center.